4/19
07:06 pm
vaxx
Vaxxinity Issues Shareholder Letter [Yahoo! Finance]
High
Report
Vaxxinity Issues Shareholder Letter [Yahoo! Finance]
4/19
06:53 pm
vaxx
Vaxxinity Issues Shareholder Letter
Medium
Report
Vaxxinity Issues Shareholder Letter
4/19
04:33 pm
vaxx
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock [Yahoo! Finance]
High
Report
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock [Yahoo! Finance]
4/19
04:27 pm
vaxx
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
High
Report
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
3/28
09:26 am
vaxx
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]
Medium
Report
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]
3/28
09:23 am
vaxx
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
Medium
Report
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
3/27
04:50 pm
vaxx
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Low
Report
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates [Yahoo! Finance]
3/27
04:41 pm
vaxx
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
Medium
Report
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
3/7
03:38 pm
vaxx
Vaxxinity gains after early-stage data for Parkinson's disease drug [Seeking Alpha]
Low
Report
Vaxxinity gains after early-stage data for Parkinson's disease drug [Seeking Alpha]
3/7
10:38 am
vaxx
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD™ 2024 [Yahoo! Finance]
Low
Report
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD™ 2024 [Yahoo! Finance]
3/7
10:32 am
vaxx
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
High
Report
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
3/4
02:01 pm
vaxx
Amprion's aSyn Seed Amplification Assay (aS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference [Yahoo! Finance]
Medium
Report
Amprion's aSyn Seed Amplification Assay (aS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference [Yahoo! Finance]